IL6 and Hodgkins lymphoma: Other studies have also proved that high level of IL-6 is implemented as a potential negative biomarker for the growth of hematologic malignancies like Hodgkin’s lymphoma (HL) [8], extranodal natural killer T cell lymphoma (ENKTL) [9] and mantle cell lymphoma (MCL) [10].